BioAge Labs Says it is Partnering With Novartis to Identify Drug Targets to Treat Age-Related Diseases

MT Newswires Live12-18

BioAge Labs (BIOA) said Wednesday it is teaming up with Novartis (NVS) to identify drug targets to treat diseases related to aging.

The multiyear research collaboration will use BioAge's human longevity data and platform and Novartis' expertise in physical exercise biology, BioAge said.

The company said under the deal, it will get up to $20 million in upfront payments and research funding and may receive up to $530 million in future long-term research, development and commercial milestones.

Each company has the right to advance novel targets discovered under the partnership and is eligible to get reciprocal success milestones and tiered royalties, BioAge said.

Shares of BioAge jumped nearly 14% and Novartis fell 0.4% in recent Wednesday trading.

Price: 4.70, Change: +0.60, Percent Change: +14.63

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2492665184?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-18 22:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2492665184","market":"sg","top_or_hot":-1,"title":"BioAge Labs Says it is Partnering With Novartis to Identify Drug Targets to Treat Age-Related Diseases","media":"MT Newswires Live","content":"<html><body><p> BioAge Labs (BIOA) said Wednesday it is teaming up with Novartis (NVS) to identify drug targets to treat diseases related to aging.</p><p>The multiyear research collaboration will use BioAge's human longevity data and platform and Novartis' expertise in physical exercise biology, BioAge said.</p><p>The company said under the deal, it will get up to $20 million in upfront payments and research funding and may receive up to $530 million in future long-term research, development and commercial milestones.</p><p>Each company has the right to advance novel targets discovered under the partnership and is eligible to get reciprocal success milestones and tiered royalties, BioAge said.</p><p>Shares of BioAge jumped nearly 14% and Novartis fell 0.4% in recent Wednesday trading.</p><p>Price: 4.70, Change: +0.60, Percent Change: +14.63</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BioAge Labs Says it is Partnering With Novartis to Identify Drug Targets to Treat Age-Related Diseases</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioAge Labs Says it is Partnering With Novartis to Identify Drug Targets to Treat Age-Related Diseases\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-18 22:50 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>BioAge Labs (BIOA) said Wednesday it is teaming up with Novartis (NVS) to identify drug targets to treat diseases related to aging.The multiyear research collaboration will use BioAge's human ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IE00B2B36J28.USD","symbol_name":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I1\" (USD) INC","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2492665184","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2492665184","pubTimestamp":1734533427,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"BioAge Labs  said Wednesday it is teaming up with Novartis  to identify drug targets to treat diseases related to aging.The multiyear research collaboration will use BioAge's human longevity data and platform and Novartis' expertise in physical exercise biology, BioAge said.The company said under the deal, it will get up to $20 million in upfront payments and research funding and may receive up to $530 million in future long-term research, development and commercial milestones.Each company has the right to advance novel targets discovered under the partnership and is eligible to get reciprocal success milestones and tiered royalties, BioAge said.Shares of BioAge jumped nearly 14% and Novartis fell 0.4% in recent Wednesday trading.Price: 4.70, Change: +0.60, Percent Change: +14.63","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"IE00B2B36J28.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I1\" (USD) INC","BK4578":"CAR-T","BK4007":"制药","IE0002141913.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (USD) ACC","IE00BFTCPJ56.SGD":"Janus Henderson Global Life Sciences A Acc SGD","IE00B4R5TH58.HKD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (HKD) ACC","IE00BJJMRZ35.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (SGDHDG) ACC","BK4585":"ETF&股票定投概念","IE0009355771.USD":"骏利亨德森环球生命科技A Acc","LU0211331839.USD":"FRANKLIN MUTUAL GLB DISCOVERY \"A\" (USD) ACC","BK4588":"碎股","BIOA":"BioAge Labs Inc.","IE00BJT1NW94.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (SGDHDG) ACC","BK4532":"文艺复兴科技持仓","NVS":"诺华"},"translate_title":"BioAge Labs表示正在与诺华合作确定治疗年龄相关疾病的药物靶点","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BIOA":1,"NVS":0.9},"content_text":"BioAge Labs (BIOA) said Wednesday it is teaming up with Novartis (NVS) to identify drug targets to treat diseases related to aging.The multiyear research collaboration will use BioAge's human longevity data and platform and Novartis' expertise in physical exercise biology, BioAge said.The company said under the deal, it will get up to $20 million in upfront payments and research funding and may receive up to $530 million in future long-term research, development and commercial milestones.Each company has the right to advance novel targets discovered under the partnership and is eligible to get reciprocal success milestones and tiered royalties, BioAge said.Shares of BioAge jumped nearly 14% and Novartis fell 0.4% in recent Wednesday trading.Price: 4.70, Change: +0.60, Percent Change: +14.63","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2492665184"}